Agile Therapeutics, Inc

Agile Therapeutics, a women's healthcare company, has been acquired by Insud Pharma, a global pharmaceutical group based in Spain. The former Agile shareholders will receive $1.52 per share in cash, and Agile will no longer be listed on any public market.

Related tickers: AGRX.

The global mother and child healthcare market is expected to grow from USD 723.67 billion in 2023 to USD 2106.78 billion by 2033, driven by factors such as increasing birth rates, growing awareness of maternal health, and advancements in healthcare products.

Related tickers: JNJ, AGRX, RBGLY, SNY, MRK.